# Drug Delivery

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/drug-delivery

- Industry: Pharmaceuticals
- Headquarters: Beijing, China
- Latest round: Series A (Mar 22, 2026)
- Investors on record: 4

## About

Founded in 2010 and based in Beijing, China, Drug Delivery is a medical technology company that focuses on the research and development of drug delivery systems. In 2019, the company won the second prize of the National Science and Technology Progress Award. In March 2026, Drug Delivery raised a series A+ funding from Shunxi Fund, Beijing E-town international Industrial Investment Management.

The company's main products include the self-emulsifying delivery technology platform for injectable poorly soluble drugs and the nano-delivery technology platform for oral poorly soluble drugs. Its R&D pipeline includes anti-tumor, cardiovascular and cerebrovascular, anti-fungal, and postoperative analgesia fields.

The company’s revenue is generated by providing drug delivery systems.

## Funding rounds

- Series A, Mar 22, 2026 — Beijing E-town international Industrial Investment Management, Shunxi Fund
- Series A, Nov 17, 2025 — BICI Capital Fortune, Guangdong Xietong Holding

## Investors

- BICI Capital Fortune (https://capitalatlas.ai/funds/bici-capital-fortune) — Series A
- Guangdong Xietong Holding — Series A
- Beijing E-town international Industrial Investment Management (https://capitalatlas.ai/funds/beijing-e-town-international-industrial-investment-managemen) — Series A
- Shunxi Fund (https://capitalatlas.ai/funds/shunxi-fund) — Series A